Overview A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects Status: COMPLETED Trial end date: 2025-07-02 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-2129 in healthy subjects.Phase: PHASE1 Details Lead Sponsor: Shandong Suncadia Medicine Co., Ltd.